Growth, weight gain and BMI in virally suppressed children on antiretroviral therapy with specific reference to dolutegravir
Abstract Background Pediatric HIV infection cause retardation in height and weight. However, effective antiretroviral therapy (ART) result in desirable weight gain. Concerns have emerged regarding excessive weight gain related to the integrase inhibitor dolutegravir in adults but knowledge about the...
Saved in:
Main Authors: | Erik Belfrage (Author), Sandra Soeria-Atmadja (Author), Lars Navér (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Weight gain on dolutegravir: Association is not the same as causation
by: Gary Maartens, et al.
Published: (2023) -
Pharmacovigilance of antiretroviral dolutegravir in the state of Paraná
by: Bárbara Thaís Poliselo de Sá, et al.
Published: (2022) -
The relationship between BMI and maternal weight gain during pregnancy with birth weight
by: Somayeh Moeindarbari, et al.
Published: (2022) -
Dolutegravir and the universal antiretroviral regimen: good may be the enemy of perfect
by: Reuben Granich, et al.
Published: (2018) -
Searching for a long-acting injectable formulation for the antiretroviral dolutegravir
by: Anderson Aparecido de Marchi, et al.
Published: (2019)